This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.56 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.56 Firm Fixed Price Delivery Order contract covers the supply of MENQUADFI VIAL 0.5ML medical products, with a period of performance through December 9, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.56 Firm Fixed Price Delivery Order is for the supply of MENQUADFI VIAL 0.5ML, a medical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $47,337.10 with a firm fixed price, and the ultimate completion date is April 27, 2023. The contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,756.20 firm fixed-price delivery order covers the supply of MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through March 8, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,281.73 firm fixed-price delivery order contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of July 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,429.76 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,053.72 firm-fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $53,183.02 firm fixed-price delivery order covers the supply of MENQUADFI VIAL 0.5ML medical products, with a completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.68 firm fixed-price delivery order covers the supply of MENQUADFI VIAL 0.5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...